暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股市場個股詳情
BDX 碧迪醫療
- 231.550
- +1.070+0.46%
收盤價 04/26 16:00 (美東)
- 231.060
- -0.490-0.21%
盤後 19:52 (美東)
668.95億總市值55.13市盈率TTM
233.160最高價230.000最低價73.82萬股成交量230.000今開230.480昨收1.71億成交額0.26%換手率46.87市盈率(靜)2.89億總股本284.01952周最高2.64市淨率667.32億流通值227.99352周最低3.68股息TTM2.88億流通股284.019歷史最高1.59%股息率TTM1.37%振幅13.066歷史最低231.626平均價1股每手
全部分時
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
資金分布
單位: --
資金流向
實時日周月
暫無數據
新聞
評論
$碧迪醫療(BDX.US$ GAME OVER stock.
Despite a dip in earnings, Becton Dickinson's high P/E ratio persists due to anticipated robust future growth, outpacing the broader market. Investors' confidence in the company's future earnings is high, indicating the share price is unlikely to drop significantly soon.
Big news
$碧迪醫療(BDX.US$ BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
2
Dr. Silverman's extensive experience and zeal for innovation, evidence generation, clinical development, medical safety, and compliance is predicted to boost BD's innovation pipeline and foster improved, personalized care.
Market sentiment towards Becton, Dickinson and Company shows no major shift in the past year. However, the rise in total shareholder return hints at a growing positivity.
閱讀更多
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅